CA2319317C - Prognostic allergy or inflammation test - Google Patents
Prognostic allergy or inflammation test Download PDFInfo
- Publication number
- CA2319317C CA2319317C CA002319317A CA2319317A CA2319317C CA 2319317 C CA2319317 C CA 2319317C CA 002319317 A CA002319317 A CA 002319317A CA 2319317 A CA2319317 A CA 2319317A CA 2319317 C CA2319317 C CA 2319317C
- Authority
- CA
- Canada
- Prior art keywords
- allergen
- ige
- linear
- allergy
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 43
- 230000007815 allergy Effects 0.000 title claims abstract description 39
- 208000026935 allergic disease Diseases 0.000 title claims abstract description 37
- 238000012360 testing method Methods 0.000 title description 14
- 206010061218 Inflammation Diseases 0.000 title description 3
- 230000004054 inflammatory process Effects 0.000 title description 3
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 47
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 44
- 230000000172 allergic effect Effects 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 35
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 34
- 150000001413 amino acids Chemical class 0.000 claims abstract description 19
- 238000012216 screening Methods 0.000 claims abstract description 17
- 239000012634 fragment Substances 0.000 claims abstract description 11
- 239000013566 allergen Substances 0.000 claims description 59
- 235000013601 eggs Nutrition 0.000 claims description 35
- 230000009257 reactivity Effects 0.000 claims description 22
- 235000013305 food Nutrition 0.000 claims description 18
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 12
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 12
- 235000018262 Arachis monticola Nutrition 0.000 claims description 12
- 235000021245 dietary protein Nutrition 0.000 claims description 12
- 235000020232 peanut Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 108010000912 Egg Proteins Proteins 0.000 claims description 6
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- 241000238631 Hexapoda Species 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 239000000428 dust Substances 0.000 claims description 4
- 235000014571 nuts Nutrition 0.000 claims description 4
- 230000002596 correlated effect Effects 0.000 claims description 2
- 230000000875 corresponding effect Effects 0.000 claims description 2
- 241001553178 Arachis glabrata Species 0.000 claims 6
- 108010011756 Milk Proteins Proteins 0.000 claims 6
- 241000251468 Actinopterygii Species 0.000 claims 3
- 108010028690 Fish Proteins Proteins 0.000 claims 3
- 102000014171 Milk Proteins Human genes 0.000 claims 3
- 108010003571 Nut Proteins Proteins 0.000 claims 3
- 108010064851 Plant Proteins Proteins 0.000 claims 3
- 108010054866 Shellfish Proteins Proteins 0.000 claims 3
- 235000021120 animal protein Nutrition 0.000 claims 3
- 235000019688 fish Nutrition 0.000 claims 3
- 235000021239 milk protein Nutrition 0.000 claims 3
- 235000021118 plant-derived protein Nutrition 0.000 claims 3
- 230000014759 maintenance of location Effects 0.000 claims 1
- 206010016946 Food allergy Diseases 0.000 abstract description 19
- 239000000427 antigen Substances 0.000 abstract description 18
- 102000036639 antigens Human genes 0.000 abstract description 18
- 108091007433 antigens Proteins 0.000 abstract description 18
- 102000004169 proteins and genes Human genes 0.000 abstract description 13
- 108090000623 proteins and genes Proteins 0.000 abstract description 13
- 208000004262 Food Hypersensitivity Diseases 0.000 abstract description 8
- 235000020932 food allergy Nutrition 0.000 abstract description 6
- 230000002797 proteolythic effect Effects 0.000 abstract description 6
- 238000004393 prognosis Methods 0.000 abstract description 5
- 238000011156 evaluation Methods 0.000 abstract description 4
- 208000027866 inflammatory disease Diseases 0.000 abstract description 4
- 108060003951 Immunoglobulin Proteins 0.000 abstract description 3
- 102000018358 immunoglobulin Human genes 0.000 abstract description 3
- 229940072221 immunoglobulins Drugs 0.000 abstract description 2
- 238000010561 standard procedure Methods 0.000 abstract description 2
- 108010064983 Ovomucin Proteins 0.000 description 60
- 230000027455 binding Effects 0.000 description 44
- 230000001186 cumulative effect Effects 0.000 description 15
- 239000012528 membrane Substances 0.000 description 14
- 239000000523 sample Substances 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 12
- 208000004739 Egg Hypersensitivity Diseases 0.000 description 11
- 201000010860 egg allergy Diseases 0.000 description 9
- 230000002009 allergenic effect Effects 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 206010012438 Dermatitis atopic Diseases 0.000 description 7
- 201000008937 atopic dermatitis Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 244000105624 Arachis hypogaea Species 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 239000013568 food allergen Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 229920000136 polysorbate Polymers 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- 208000015943 Coeliac disease Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000008267 Peanut Hypersensitivity Diseases 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000030741 antigen processing and presentation Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 210000004837 gut-associated lymphoid tissue Anatomy 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000001024 immunotherapeutic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001785 maturational effect Effects 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 201000010853 peanut allergy Diseases 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NSMXQKNUPPXBRG-SECBINFHSA-N (R)-lisofylline Chemical group O=C1N(CCCC[C@H](O)C)C(=O)N(C)C2=C1N(C)C=N2 NSMXQKNUPPXBRG-SECBINFHSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001203952 Feia Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 208000020226 Heiner syndrome Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 208000002366 Nut Hypersensitivity Diseases 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000746983 Phleum pratense Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013567 aeroallergen Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108091005588 alkylated proteins Proteins 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000000837 carbohydrate group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 210000004124 hock Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001629 sign test Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7317198P | 1998-01-30 | 1998-01-30 | |
| US60/073,171 | 1998-01-30 | ||
| PCT/US1999/001832 WO1999039211A1 (en) | 1998-01-30 | 1999-01-28 | Prognostic allergy or inflammation test |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2319317A1 CA2319317A1 (en) | 1999-08-05 |
| CA2319317C true CA2319317C (en) | 2006-04-18 |
Family
ID=22112157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002319317A Expired - Fee Related CA2319317C (en) | 1998-01-30 | 1999-01-28 | Prognostic allergy or inflammation test |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6238925B1 (https=) |
| EP (2) | EP1939628B1 (https=) |
| JP (1) | JP4292262B2 (https=) |
| AT (2) | ATE426170T1 (https=) |
| AU (1) | AU741635B2 (https=) |
| CA (1) | CA2319317C (https=) |
| DE (1) | DE69919327D1 (https=) |
| ES (2) | ES2383002T3 (https=) |
| WO (1) | WO1999039211A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10110838C2 (de) * | 2001-03-06 | 2003-04-03 | Mlu Halle Wittenberg | Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen |
| EP1410037A2 (de) * | 2001-03-10 | 2004-04-21 | Affina Immuntechnik GmbH | Verfahren zur identifikation von immunreaktiven epitopen auf proteinen und verwendung der epitope zu prophylaktischen und therapeutischen zwecken |
| RU2214599C2 (ru) * | 2001-11-21 | 2003-10-20 | Самарский медицинский институт "РЕАВИЗ" | Способ выявления лиц, относящихся к группе риска по развитию аллергических заболеваний |
| CN101318019B (zh) | 2003-04-23 | 2012-08-29 | 梅达雷克斯公司 | 含1型干扰素拮抗剂的组合物及其在制备治疗炎症性肠病的药物中的用途 |
| HUE035082T2 (en) | 2004-06-21 | 2018-05-02 | Squibb & Sons Llc | Interferon alpha receptor 1 antibodies and their use |
| US8859210B2 (en) * | 2008-10-17 | 2014-10-14 | Mead Johnson Nutrition Company | Method for identifying allergenic proteins and peptides |
| JP5660027B2 (ja) * | 2009-03-05 | 2015-01-28 | 味の素株式会社 | クローン病診断試薬 |
| EP3492922B1 (en) * | 2009-09-14 | 2025-11-05 | Icahn School of Medicine at Mount Sinai | Methods for characterizing antibody binding affinity and epitope diversity in food allergy |
| WO2012135313A1 (en) * | 2011-03-28 | 2012-10-04 | University Of Massachusetts | Compositions and methods for detecting allergy to a-gal epitopes |
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| CN105188741A (zh) | 2013-04-03 | 2015-12-23 | 阿勒丁医疗公司 | 新型纳米颗粒组合物 |
| KR102202575B1 (ko) | 2013-12-31 | 2021-01-13 | 삼성전자주식회사 | 메모리 관리 방법 및 장치 |
| CN106662578B (zh) * | 2014-04-03 | 2021-11-12 | 艾勒詹尼斯有限责任公司 | 用于检测食物变态反应的肽、试剂和方法 |
| CN113671173A (zh) | 2014-11-14 | 2021-11-19 | 拜尔梅里科有限公司 | Ibs敏感度测试的组合物、设备以及方法 |
| EP3173789A1 (en) * | 2015-11-24 | 2017-05-31 | Helmholtz-Zentrum für Infektionsforschung GmbH | Method for differentiation of immune response in an individual |
| CN116183929A (zh) * | 2016-04-26 | 2023-05-30 | 拜尔梅里科有限公司 | 溃疡性结肠炎敏感测试的组合物、设备以及方法 |
| EP3457134B1 (en) * | 2016-05-13 | 2021-04-28 | Applied Medical Enzyme Research Institute Corporation | Method for collecting data to predict risk of developing allergies |
| RU2621312C1 (ru) * | 2016-06-15 | 2017-06-01 | Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) | Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста |
| KR102327467B1 (ko) * | 2016-06-16 | 2021-11-16 | 호유 가부시키가이샤 | 생선 알레르기의 항원 |
| EP3497447B1 (en) | 2016-07-08 | 2024-09-04 | Biomerica, Inc. | Compositions, devices, and methods of depression sensitivity testing |
| CN110716055A (zh) * | 2019-09-11 | 2020-01-21 | 天津医科大学 | 过敏原特异性免疫球蛋白e致病活性检测试剂盒 |
| US11143650B1 (en) * | 2020-04-15 | 2021-10-12 | ProteinSimple | Method for measurement of total protein content and detection of protein via immunoassay in a microfluidic device |
| JP7808810B2 (ja) * | 2020-09-07 | 2026-01-30 | 三菱瓦斯化学株式会社 | アレルギー疾患の判定方法及び判定システム |
| JP7555788B2 (ja) * | 2020-10-30 | 2024-09-25 | アサヒグループホールディングス株式会社 | タンパク質の起源種判別方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736362A (en) * | 1990-10-26 | 1998-04-07 | The University Of Melbourne | Ryegrass pollen allergen |
| US5567594A (en) * | 1991-04-26 | 1996-10-22 | Enteron, L.P. | Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| US5480972A (en) * | 1992-10-30 | 1996-01-02 | The University Of Melbourne | Allergenic proteins from Johnson grass pollen |
| US5558869A (en) * | 1992-12-30 | 1996-09-24 | University Of Arkansas | Major peanut allergen ara h II |
| ATE318902T1 (de) * | 1992-12-31 | 2006-03-15 | Immulogic Pharma Corp | Allergene proteine und peptide von hundhautanhangsgebilden und ihre verwendung |
-
1999
- 1999-01-28 ES ES08005972T patent/ES2383002T3/es not_active Expired - Lifetime
- 1999-01-28 WO PCT/US1999/001832 patent/WO1999039211A1/en not_active Ceased
- 1999-01-28 ES ES99903464T patent/ES2229673T3/es not_active Expired - Lifetime
- 1999-01-28 US US09/238,448 patent/US6238925B1/en not_active Expired - Lifetime
- 1999-01-28 CA CA002319317A patent/CA2319317C/en not_active Expired - Fee Related
- 1999-01-28 EP EP08005972A patent/EP1939628B1/en not_active Expired - Lifetime
- 1999-01-28 DE DE69919327T patent/DE69919327D1/de not_active Expired - Lifetime
- 1999-01-28 AU AU23478/99A patent/AU741635B2/en not_active Ceased
- 1999-01-28 JP JP2000529614A patent/JP4292262B2/ja not_active Expired - Fee Related
- 1999-01-28 AT AT99903464T patent/ATE426170T1/de not_active IP Right Cessation
- 1999-01-28 EP EP99903464A patent/EP1051626B1/en not_active Expired - Lifetime
- 1999-01-28 AT AT08005972T patent/ATE550665T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2383002T3 (es) | 2012-06-15 |
| JP4292262B2 (ja) | 2009-07-08 |
| DE69919327D1 (de) | 2009-11-26 |
| EP1051626B1 (en) | 2009-03-18 |
| HK1032262A1 (en) | 2001-07-13 |
| EP1939628A1 (en) | 2008-07-02 |
| DE69919327T2 (de) | 2005-03-10 |
| JP2002502039A (ja) | 2002-01-22 |
| EP1051626A1 (en) | 2000-11-15 |
| AU741635B2 (en) | 2001-12-06 |
| CA2319317A1 (en) | 1999-08-05 |
| US6238925B1 (en) | 2001-05-29 |
| ATE550665T1 (de) | 2012-04-15 |
| EP1939628B1 (en) | 2012-03-21 |
| HK1120865A1 (en) | 2009-04-09 |
| WO1999039211A1 (en) | 1999-08-05 |
| ATE426170T1 (de) | 2009-04-15 |
| ES2229673T3 (es) | 2009-08-04 |
| AU2347899A (en) | 1999-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2319317C (en) | Prognostic allergy or inflammation test | |
| Järvinen et al. | Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy | |
| EP2478373B1 (en) | Methods for characterizing antibody binding affinity and epitope diversity in food allergy | |
| EP2136211B1 (en) | Determination method for allergic disease | |
| US20150168389A1 (en) | Methods Of Determining Allergen Response Using Microarray Immunoassay Techniques | |
| ES2788389T3 (es) | Ensayo mejorado para el diagnóstico de alergia al cacahuete | |
| CN113287013A (zh) | 溃疡性大肠炎以及原发性硬化性胆管炎的检查方法 | |
| US7258994B2 (en) | Saliva immunoassay for detection of antibodies for cardiovascular disease | |
| JP5633721B2 (ja) | 乳幼児のアレルギー発症を予測するためのデータを提供する方法 | |
| CN109952510A (zh) | 收集用于预测过敏发病风险的数据的方法 | |
| Germano et al. | Specific humoral response to cows’ milk proteins and ovalbumin in children with atopic dermatitis | |
| JP7385302B2 (ja) | アナフィラキシーの発症を予測するためのデータを収集する方法 | |
| HK1032262B (en) | Prognostic allergy or inflammation test | |
| HK1120865B (en) | Prognostic allergy test | |
| US20030100035A1 (en) | Saliva immunoassay for detection of antibodies for autoimmune disease | |
| JP2022096812A (ja) | 抗原ポリペプチド | |
| JP7585025B2 (ja) | 歯周病原菌に対する抗体価を測定する方法 | |
| JP2026049460A (ja) | リンパ球性下垂体前葉炎及びその類縁疾患を検査するための試薬及びその利用 | |
| Laan et al. | MARKERS FOR EARLY SENSITISATION AND INFLAMMATION | |
| Raesan et al. | Preparation of allergenfrom chicken egg and evaluated of their abilityto anaphylaxis's in patients suffering from allergy. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20150128 |